<p>The book deals with therapeutic monoclonal antibodies (mAbs) broadly and relevant topics such as challenges and opportunities next-generation antibody products Antibody-Drug-Conjugates (ADC) bispecifics glycosylation and T-cell engagers are covered. Each topic has been written by leading groups around the world and the book should be of interest to researchers from both academia and industry.</p>